Neurocrine Biosciences Reports Second Quarter 2016 ResultsYahoo FinanceIn addition, four valbenazine scientific abstracts were presented at the American Psychiatric Association Annual Meeting in May. Data from Kinect 3 was also shared at the 20th International Congress of Parkinson's Disease and Movement Disorders in ...Neurocrine Biosciences' (NBIX) CEO Kevin Gorman on Q2 2016 Results - Earnings Call TranscriptSeeking Alphaall 3 news articles »